Yakasai, Other Health Professionals Endorse Publitem Anti-Malarials (PHOTOS)

0
2005
In its sustained campaign against malaria, several health professionals including Pharm Ahmed Yakasai, incumbent president of the Pharmaceutical Society of Nigeria (PSN) have thrown their weight behind the introduction of Publitem range of Artemether (80)-Lumefantrine (480) anti-malarial (tablets and suspension) into the Nigerian pharma market.
Above other things, the new range of products, exclusively launched today by Publix Pharmaceuticals (Nigeria) Limited at Protea Hotel, Ikeja, is expected to feature an additional level of security popularly known as Mobile Authentication Service (MAS) label, which allows people to verify the authenticity of the product.
Addressing journalist at the event, Chief Frank Owelle, chairman of Publix Pharmaceuticals explained that all the patient or consumer simply needs to do is to scratch off the label to reveal a unique 12-digit number.
“Once activated, it gives automatic feedback on whether the code is valid or not within seconds,” he remarked.
L-R: Mrs Angela Rutaguza, Publix director; S. K. Chattopadhyan, chief medical director, GLIL, India; Pharm Ahmed Yakasai, president, Pharmaceutical Society of Nigeria (PSN); Chief Frank Owelle, chairman of Publix Pharmaceuticals  and Pharm. Davies Akindele, Publix pharmacist director
In attendance at the event were S. K. Chattopadhyan, chief medical director, GLIL, India; Chief Dr Gabriel Onyejemuo, chairman, Gabo Pharmaceuticals Industries; Pharm Ahmed Yakasai, president, Pharmaceutical Society of Nigeria (PSN); Mrs Angela Rutaguza, Publix director; Pharm. Davies Akindele, Publix pharmacist director and Mrs. Medinat Rasheed, Publix head of accounts.
Speaking further on why the products launch coincided with the 2017 World Malaria Day commemoration celebration, Owelle disclosed that there could not have been a better time to launch the antimalarials than now.
“In line with this year’s theme, END MALARIA FOR GOOD, Publix Pharmaceuticals has joined the fight against malaria by introducing into the Nigerian market our brand of top quality WHO recommended ACT formulation 80/480,” he noted.
UNVEILING THE PRODUCTS:  S. K. Chattopadhyan, chief medical director, GLIL, India; Pharm. Davies Akindele, Publix pharmacist director; Dr Chris Otigbu, consultant physician / haematologist; Chief Frank Owelle, chairman of Publix Pharmaceuticals; Pharm Ahmed Yakasai, president, Pharmaceutical Society of Nigeria (PSN) and Mrs Angela Rutaguza, Publix director; 
 
 
Applauding the product launch, Pharm Ahmed Yakasai, president, Pharmaceutical Society of Nigeria (PSN) reiterated that since Chloroquin has fallen out of favour, Artemether-Lumefantrine has now become the first line of treatment.
“When we have more of this brand of ACTs, it will crash the high cost of anti-malarial products in the market. This is why we hope more local pharma manufacturers can come into the market.
“I was privileged to visit Publitem producer, Astamed Healthcare’s factory in India and I can tell you it is world class. I think Publix has done well and should be commended,” he stressed.
Dr Chris Otigbu, consultant physician / haematologist seems to be in agreement with him.

“As no government hospital can claim to have all required facilities and products, the health of the nation has been left in the hands of individuals. I really don’t see any reason why we cannot support Publitem,” he enthused.

READ
DID SHE GOOF? Queen Elizabeth II Claims Malaria Deadlier Than Ebola

LEAVE A REPLY

Please enter your comment!
Please enter your name here